IFN-α receptor mRNA expression in a united states sample with predominantly genotype 1a/I chronic hepatitis C liver biopsies correlates with response to IFN therapy

Journal of Interferon and Cytokine Research

Volumn 19, Issue 9, 1999, Pages 1011-1018

  Mathai, Jijy ^a   Shimoda, Katsuhiro ^a   Banner, Barbara F ^a   Mori, Masaki ^b   Bonkovsky, Herbert L ^a   Barnard, Graham F ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON RECEPTOR; CONSENSUS INTERFERON; INTERFERON; MESSENGER RNA; RECOMBINANT ALPHA2B INTERFERON; VIRUS RNA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENOTYPE; HEPATITIS C; HISTOLOGY; HUMAN; HUMAN TISSUE; JAPAN; LIVER BIOPSY; LIVER FIBROSIS; LIVER NECROSIS; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UNITED STATES;

ADULT; ANTIVIRAL AGENTS; BIOPSY; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2B; LIVER; MALE; RECEPTOR, INTERFERON ALPHA-BETA; RECEPTORS, INTERFERON; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TREATMENT OUTCOME; UNITED STATES;

EID: 0032831248     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/107999099313226     Document Type: Article

References (38)

1. BARON, S., TYRING, S.K., FLEISHMANN, W.R., COPPENHAVER, D.H., NIESEL, D.W., KLIMPEL, G.R., STANTON, J., and HUGHES, T.K. (1991). The interferons: mechanisms of action and clinical applications. JAMA 266, 1375-1383.
2. PFEFFER, L.M., DINARELLO, C.A., HERBERMAN, R.B., WILLIAMS, B.R.G., BORDEN, E.C., BORDENS, R., WALTER, M.R., NAGABHUSHAN, T.L., TROTTA, P.P., and PESTKA, S. (1998). Biological properties of recombinant alpha-interferons: 40th anniversary of the discovery of interferons. Cancer Res. 58, 2489-2499.
3. DE MAEYER, E., and DE MAEYER-GUIGNAND, J. (eds.) (1988). Interferon and Other Regulatory Cytokines. New York: John Wiley & Sons, pp. 91-113.
4. LAU, A.S., HANNINGEN, G.E., FREEDMAN, M.H., and WILLIAMS, B.R.G. (1986). Regulation of IFN receptor expression in human blood lymphocytes in vitro and during interferon therapy. J. Clin. Invest. 77, 1632-1638.
5. FUKUDA, R., ISHIMURA, N., KUSHIYAMA, Y., MORIYAMA, N., ISHIHARA, S., NAGASAWA, S., MTYAKE, T., NIIGAKI, M., SATOH, S., SAKAI, S., AKAGI, S., WATANABE, M., and FUKUMOTO, S. (1997). Effectiveness of interferon-alpha receptor mRNA in the liver. J. Hepatol. 26, 455-461.
6. LAU, J.Y.N., SHERON, N., MORRIS, A.C., BOMFORD, A.B., ALEXANDER, G.J.M., and WILLIAMS, R. (1991). IFN-α receptor expression and regulation in chronic hepatitis B virus infection. Hepatology 15, 332-328.
7. MULLER, U., STEIHOFF, U., REIS, L.F., HEMMI, S., PAVLOVIC, J., ZINKERNAGEL, R.M., and AGUET, M. (1994). Functional roles of type I and type II interferon in anti-viral defense. Science 264, 1918-21.
8. LINDSAY, K.L. (1997). Therapy of hepatitis C: overview. Hepatology 26, 71S-77S.
9. KOFF, R.S. (1997). Interferon-α for chronic HCV: reducing the uncertainties. Ann. Intern. Med. 127, 918-920.
10. HOOFNAGLE, J.H., and DI BISCEGLIE, A.M. (1997). The treatment of chronic viral hepatitis. N. Engl. J. Med. 336, 347-356.
11. MARTINOT-PEIGNOUX, M., MARCELLIN, P., POUTEAU, M., CASTELNAU, C., BOYER, N., POLIQUIN, M., DEGOTT, C., DESCOMBES, I., LE BRETON, V., MILOTOVA, V., BENHAMOU, J.P., and ERLINGER, S. (1995). Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alpha therapy in chronic hepatitis C. Hepatology 22, 1050-1056.
12. CHAN, S.-W., McOMISH, F., HOLMES, E.C., DOW, B., PEUTHERER, J.F., FOLLETT, E., YAP, P.L., and SIMMONDS, P. (1992). Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants. J. Gen. Virol. 73, 1131-1141.
13. SIMONDS, P., ALBERTI, A., ALTER, H.J., BONINO, F., BRADLEY, D.W., BRECHOT, C., BROUWER, J.T., CHAN, S.-W., CHAYAMA, K., CHEN, D.-S., CHOO, Q.L., COLOMBO, M., CUYPERS, H.T.M., DATE, T., DUSHEIKO, G.M., ESTABAN, J.I., FAY, O., et al. (1994). A proposed system for the nomenclature of hepatitis C viral genotype. Hepatology 19, 1321-1324.
14. OKAMOTO, H., KURAI, K., OKADA, S.-I., YAMAMOTO, K., LIZUKA, H., TANAKA, T., TSUDA, F., and MISHIRO, S. (1992). Full-length sequence of a hepatitis C virus genome having poor homology to reported isolates: comparative study of four distinct genotypes. Virology 188, 331-341.
15. BUKH, J., MILLER, R.H., and PURCELL, R.H. (1995). Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes. Semin. Liver Dis. 15, 41-63.
16. BANNER, B.F., BARTON, A.L., CABLE, E.E., SMITH, L., and BONKOVSKY, H.L. (1995). A detailed analysis of the Knodell score and other histologic parameters as predictors of response to interferon therapy in chronic hepatitis C. Mod. Pathol. 8, 232-238.
17. BONKOVSKY, H.L., BANNER, B.F., and ROTHMAN, A.L. (1997). Iron and chronic viral hepatitis. Hepatology 25, 759-768.
18. FUKUDA, R., ISHIMURA, N., ISHIHARA, S., TOKUDA, A., SATOH, S., SAKAI, S., AKAGI, S., WATANABE, M., and FUKUMOTO, S. (1996). Expression of interferon-alpha receptor mRNA in the liver in chronic liver diseases associated with hepatitis C virus - relation to effectiveness of interferon therapy. J. Gastroenterol. 31, 806-811.
19. ISHIMURA, N., FUKUDA, R., and FUKUMOTO, S. (1996). Relationship between the intrahepatic expression of interferon alpha receptor mRNA and the histologic progress of hepatitis C virus associated chronic liver disease. J. Gastroenterol. Hepatol. 11, 712-717.
20. YATSUHASHI, H., YAMASAKI, K., ARITOMI, T., MARIA, P., CARMAN, D., INOUE, O., KOGA, M., and YANO, M. (1997). Quantitative analysis of Interferon alpha/beta receptor mRNA in the liver of patients with chronic hepatitis C: correlation with serum hepatitis C virus levels and response to treatment with interferon. J. Gastroenterol. Hepatol. 12, 460-467.
21. KNODELL, R.G., ISHAK, K.G., BLACK, W.C., CHEN, T.S., CRAIG, R., KAPLOWITZ, N., KIERNAN, T.W., and WOLLMAN, J. (1981). Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1, 431-435.
22. CHOMCZYNSKI, P., and SACCHI, N. (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159.
23. SHIBUTA, K., BEGUM, N.A., MORI, M., SHIMODA, K., AKIYOSHI, T., and BARNARD, G.F. (1997). Reduced expression of hIRH/SDF1α/PBSF in gastrointestinal tract cancers. Int. J. Cancer 73, 656-662.
24. SHIMODA, K., BEGUM, N.A., SHIBUTA, K., MORI, M., BONKOVSKY, H.L., BANNER, B.F., and BARNARD, G.F. (1998). Interleukin-8 and hIRH (SDF1-α/PBSF mRNA expression and histological activity index in patients with chronic hepatitis C. Hepatology 28, 108-115.
25. KANAI, K., KAKO, M., and OKAMOTO, H. (1992). HCV genotypes in chronic hepatitis C and response to interferon. Lancet 339, 1543.
26. YOSHIOKA, K., KAKUMU, S., WAKITA, T., ISHIKAWA, T., ITOH, Y., TAKAYAMAKI, M., HIGASHI, Y., SHIBATA, M., and MORISHIMA, T. (1992). Detection of HCV by PCR and response to interferon alpha therapy: relationship to genotypes of hepatitis C virus. Hepatology 16, 293-299.
27. FUKUDA, R., ISHIMURA, N., NGUYEN, X.T., CHOWDHURY, A., ISHIHARA, S., KOHGE, N., AKAGI, S., WATANABE, M., and FUKUMOTO, S. (1995). The expression of IL-2, IL-4 and IFN-gamma mRNA using liver biopsies at different phases of acute exacerbation of chronic hepatitis B. Clin. Exp. Immunol. 100, 446-451.
28. PIRISI, M., FABRIS, C., TONIUTTO, P., FALLETI, E., TISMINETZKY, S.G., GEROTTO, M., SOARDO, G., VITULLI, D., DEL FORNO, M., BARELLE, F., and BARTOLI, E. (1997). Endogeneous interferon-α concentration and outcome of interferon treatment in patients with chronic hepatitis C. Dig. Dis. Sci. 42, 767-771.
29. FUKUDA, R., ISHIMURA, N., ISHIHARA, S., CHOWDHURY, A., MORLYAMA, N., NOGAMI, C., MIYAKI, T., NIIGAKI, M., TOKUDA, A., SATOH, S., SAKAI, S., AKAGI, S., WATANABE, M., and FUKUMOTO, S. (1996). Intrahepatic expression of pro-inflammatory cytokine mRNAs and interferon efficacy in chronic hepatitis C. Liver 16, 390-399.
30. FUKUDA, R., SATOH, S., NGUYEN, X.T., UCHIDA, Y., KOHGE, N., AKAGI, S., IKEDA, S., WATANABE, M., and FUKUMOTO, S. (1995). Expression rate of cytokine mRNA in the liver of chronic hepatitis C: comparison with chronic hepatitis B. J. Gastroenterol. 30, 41-47.
31. NOVICK, D., COHEN, B., and RUBINSTEIN, M. (1994). The human interferon alpha/beta receptor: characterization and molecular cloning. Cell 77, 391-400.
32. UZE, G., LUTFALLA, G., and GRESSER, I. (1990). Genetic transfer of a functional human interferon alpha receptor into mouse cells: cloning and expression of its cDNA. Cell 60, 225-234.
33. KUROSAKI, M., ENOMOTO, N., MURAKAMI, T., SAKUMA, I., ASAHINA, Y., YAMAMOTO, C., IKEDA, T., TOZUKA, S., IZUMI, N., MARUMO, F., and SATO, C. (1997). Analysis of genotypes and amino acid residues 2209-2248 of the NS5A region of hepatitis C virus in relation to the response to interferon-β therapy. Hepatology 25, 750-753.
34. HERON, D., and HOOFNAGLE, J.H. (1997). The interferon sensitivity determining region: all hepatitis C virus isolates are not the same. Hepatology 25, 769-771.
35. AFFABRIS, E., ROMEO, G., BELARDELLI, F., JEMMA, C., MECHTI, N., GRESSER, I., and ROSSI, G.B. (1983), 2-5A Synthetase activity does not increase in interferon-resistant Friend leukemia cell variants treated with alpha/beta interferon despite the presence of high-affinity receptor sites. Virology 125, 508-512.
36. GIBBS, V.C., TAKAHASHI, M., AGUET, M., and CHUNTHARAPAI, A. (1996). A negative regulatory region in the intracellular domain of the human interferon-alpha receptor. J. Biol. Chem, 171, 28710-28716.
37. PETRICOIN, E.F., ITO, S., WILLIAMS, B.L., AUDET, S., STANCATO, L.F., GAMERO, A., CLOUSE, K., GRIMLEY, P., WEISS, A., BEELER, J., FINBLOOM, D.S., SHORES, E.W., ABRAHAM, R., and LARNER, A.C. (1997). Antiproliferative action of IFN-alpha requires components of T-cell receptor signalling. Nature 390, 629-632.
38. BRANCA, A.A., and BAGLIONI, C. (1982). Down regulation of IFN receptor. J. Biol. Chem. 257, 13197-13200.